Results 281 to 290 of about 152,571 (346)
Some of the next articles are maybe not open access.
Reduction of PTSD Symptoms With Pre-Reactivation Propranolol Therapy: A Randomized Controlled Trial
American Journal of Psychiatry, 2018Alain Brunet +2 more
exaly +2 more sources
Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review
Pediatrics, 2016Olivia Boccara, Sorilla Prey
exaly +2 more sources
Reactions Weekly, 2017
Propranolol is a noncardioselective β-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrinsic sympathomimetic activity. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.
Abdulrahman A, Al-Majed +4 more
openaire +3 more sources
Propranolol is a noncardioselective β-blocker. It is reported to have membrane-stabilizing properties, but it does not own intrinsic sympathomimetic activity. Propranolol hydrochloride is used to control hypertension, pheochromocytoma, myocardial infarction, cardiac arrhythmias, angina pectoris, and hypertrophic cardiomyopathy.
Abdulrahman A, Al-Majed +4 more
openaire +3 more sources
Micro and Nanosystems, 2020
The objective of the present work was to develop transethosomes loaded with propranolol hydrochloride using Lipoid S100 as phospholipid, and oleic acid as permeation enhancer and evaluate them for prolonged release effect, in-vitro skin permeation, and
L R Amruth Kumar, Puneet Utreja
semanticscholar +1 more source
The objective of the present work was to develop transethosomes loaded with propranolol hydrochloride using Lipoid S100 as phospholipid, and oleic acid as permeation enhancer and evaluate them for prolonged release effect, in-vitro skin permeation, and
L R Amruth Kumar, Puneet Utreja
semanticscholar +1 more source
The American Journal of Cardiology, 1966
Abstract Propranolol was given by mouth to 9 hypertensive patients in doses of 30 mg. rising to 150 or 300 mg. a day over the course of 8 to 15 weeks. There was a modest fall in blood pressure during teatment. Symptoms were slight or absent, and no toxic effects were noted.
B N, Prichard, P M, Gillam
openaire +4 more sources
Abstract Propranolol was given by mouth to 9 hypertensive patients in doses of 30 mg. rising to 150 or 300 mg. a day over the course of 8 to 15 weeks. There was a modest fall in blood pressure during teatment. Symptoms were slight or absent, and no toxic effects were noted.
B N, Prichard, P M, Gillam
openaire +4 more sources
Clinical pharmacology and therapy, 2020
Propranolol suppresses tumor growth in a variety of preclinical solid tumor models, with a number of proposed cell signaling and immunological mechanisms. We want to confirm the potential mechanisms, including reduced phosphorylation of AKT/MAPK pathways,
P. Liao +13 more
semanticscholar +1 more source
Propranolol suppresses tumor growth in a variety of preclinical solid tumor models, with a number of proposed cell signaling and immunological mechanisms. We want to confirm the potential mechanisms, including reduced phosphorylation of AKT/MAPK pathways,
P. Liao +13 more
semanticscholar +1 more source
Journal of Plastic Surgery and Hand Surgery, 2013
A slow-involuting segmental haemangioma was initially treated conventionally. Proliferation recurred when treatment was stopped. When the effect of propranolol on haemangiomas was published, we treated this 2.5- year- old girl with it. The haemangioma finally regressed recorded on magnetic resonance imaging and at clinical follow-up.
Engberg Damsgaard, Tine +1 more
openaire +2 more sources
A slow-involuting segmental haemangioma was initially treated conventionally. Proliferation recurred when treatment was stopped. When the effect of propranolol on haemangiomas was published, we treated this 2.5- year- old girl with it. The haemangioma finally regressed recorded on magnetic resonance imaging and at clinical follow-up.
Engberg Damsgaard, Tine +1 more
openaire +2 more sources
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1983
1. 15 schizophrenic patients diagnosed according to criteria of I.C.D.-9 were treated with d1-propranolol in a 4 week open study. 2. A fixed dose schedule was followed and a maximum dose of 1920 mg/day was reached by day 17. 3. Results revealed a significant reduction in core schizophrenic symptoms of CPRS & BPRS starting between 1st and second weeks ...
B B, Sethi, S, Dubé
openaire +2 more sources
1. 15 schizophrenic patients diagnosed according to criteria of I.C.D.-9 were treated with d1-propranolol in a 4 week open study. 2. A fixed dose schedule was followed and a maximum dose of 1920 mg/day was reached by day 17. 3. Results revealed a significant reduction in core schizophrenic symptoms of CPRS & BPRS starting between 1st and second weeks ...
B B, Sethi, S, Dubé
openaire +2 more sources